JIP
ZOM

Jaffetilchin Investment Partners’s Zomedica Corp. ZOM Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,500
Closed -$4K – 348
2022
Q1 		$4K Hold
20,500
– – ﹤0.01% 319
2021
Q4 		$6K Hold
20,500
– – ﹤0.01% 345
2021
Q3 		$11K Sell
20,500
-20,500
-50% -$12.1K ﹤0.01% 363
2021
Q2 		$22K Buy
41,000
+20,500
+100% +$19.1K ﹤0.01% 369
2021
Q1 		$32K Hold
20,500
– – ﹤0.01% 361
2020
Q4 		$5K Buy
+20,500
New +$2.61K ﹤0.01% 274

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Jaffetilchin Investment Partners's ZOM Position: Q2 2022 in Review

Jaffetilchin Investment Partners sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 20,500 shares — an estimated $4K sold.

Jaffetilchin Investment Partners first reported a position in ZOM in Q4 2020 and held it in 6 quarters. The position peaked at $32K in Q1 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • Jaffetilchin Investment Partners reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 20,500 Zomedica Corp. shares in Q2 2022, an estimated $4K.
  • Jaffetilchin Investment Partners first reported a position in Zomedica Corp. in Q4 2020 and held it in 6 quarters.
  • Jaffetilchin Investment Partners's Zomedica Corp. position peaked at $32K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2022, filed 15 Aug 2022.